Chemed (Germany) Performance
| CXM Stock | EUR 525.00 10.00 1.94% |
The firm shows a Beta (market volatility) of -0.23, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Chemed are expected to decrease at a much lower rate. During the bear market, Chemed is likely to outperform the market. At this point, Chemed has a negative expected return of -0.0805%. Please make sure to confirm Chemed's coefficient of variation, total risk alpha, skewness, as well as the relationship between the information ratio and maximum drawdown , to decide if Chemed performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Chemed has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Chemed is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 32.9 M | |
| Free Cash Flow | 252.6 M |
Chemed |
Chemed Relative Risk vs. Return Landscape
If you would invest 55,947 in Chemed on October 30, 2024 and sell it today you would lose (3,447) from holding Chemed or give up 6.16% of portfolio value over 90 days. Chemed is currently producing negative expected returns and takes up 2.2063% volatility of returns over 90 trading days. Put another way, 19% of traded stocks are less volatile than Chemed, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Chemed Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Chemed's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Chemed, and traders can use it to determine the average amount a Chemed's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0365
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CXM |
Estimated Market Risk
| 2.21 actual daily | 19 81% of assets are more volatile |
Expected Return
| -0.08 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.04 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Chemed is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Chemed by adding Chemed to a well-diversified portfolio.
Chemed Fundamentals Growth
Chemed Stock prices reflect investors' perceptions of the future prospects and financial health of Chemed, and Chemed fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Chemed Stock performance.
| Return On Equity | 0.35 | |||
| Return On Asset | 0.16 | |||
| Profit Margin | 0.12 % | |||
| Operating Margin | 0.16 % | |||
| Current Valuation | 7.54 B | |||
| Shares Outstanding | 14.95 M | |||
| Price To Earning | 32.25 X | |||
| Price To Book | 10.47 X | |||
| Price To Sales | 3.39 X | |||
| Revenue | 2.13 B | |||
| EBITDA | 393.44 M | |||
| Cash And Equivalents | 3.32 M | |||
| Cash Per Share | 0.21 X | |||
| Total Debt | 92.5 M | |||
| Debt To Equity | 30.10 % | |||
| Book Value Per Share | 53.70 X | |||
| Cash Flow From Operations | 309.89 M | |||
| Earnings Per Share | 15.57 X | |||
| Total Asset | 1.44 B | |||
About Chemed Performance
By analyzing Chemed's fundamental ratios, stakeholders can gain valuable insights into Chemed's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Chemed has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Chemed has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. Chemed Corporation was founded in 1970 and is headquartered in Cincinnati, Ohio. CHEMED CORP operates under Medical Care classification in Germany and is traded on Frankfurt Stock Exchange. It employs 15707 people.Things to note about Chemed performance evaluation
Checking the ongoing alerts about Chemed for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Chemed help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Chemed generated a negative expected return over the last 90 days | |
| Chemed has accumulated 92.5 M in total debt with debt to equity ratio (D/E) of 30.1, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Chemed has a current ratio of 0.79, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Chemed until it has trouble settling it off, either with new capital or with free cash flow. So, Chemed's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Chemed sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Chemed to invest in growth at high rates of return. When we think about Chemed's use of debt, we should always consider it together with cash and equity. | |
| Over 95.0% of Chemed shares are held by institutions such as insurance companies |
- Analyzing Chemed's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Chemed's stock is overvalued or undervalued compared to its peers.
- Examining Chemed's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Chemed's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Chemed's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Chemed's stock. These opinions can provide insight into Chemed's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Chemed Stock analysis
When running Chemed's price analysis, check to measure Chemed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chemed is operating at the current time. Most of Chemed's value examination focuses on studying past and present price action to predict the probability of Chemed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chemed's price. Additionally, you may evaluate how the addition of Chemed to your portfolios can decrease your overall portfolio volatility.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |